文献速递头颈外科

p16阳性N3期口咽鳞状细胞癌患者的吸烟与乳头状瘤病毒DNA

Smoking and papillomavirus DNA in patients with p16-positive N3 oropharyngeal squamous cell carcinoma.
PubMed 文献 · Head Neck · 2018-12-15

回顾性分析2003至2016年在本癌症中心治疗的29例p16阳性N3期口咽鳞状细胞癌患者,5年总生存率和无进展生存率分别为67.5%和59.1%。吸烟史超过10包年和缺乏人乳头瘤病毒DNA与更差的总生存和无进展生存相关,诱导化疗或根治性颈清扫未与不同治疗结局相关。

要点

  • p16阳性N3期口咽鳞状细胞癌患者5年总生存率为67.5%,无进展生存率为59.1%。
  • 吸烟史超过10包年与更差的总生存(P=0.02)和无进展生存(P=0.02)相关。
  • 缺乏人乳头瘤病毒DNA与更差的总生存(P=0.03)和无进展生存(P=0.02)相关。

核心结论

  • 本系列p16阳性N3期口咽鳞状细胞癌患者的5年总生存率为67.5%。
  • 吸烟史和病毒DNA是与生存相关的预后因素。

研究设计与样本

  • 回顾性分析2003年至2016年在本癌症中心治疗的p16阳性N3期口咽鳞状细胞癌患者数据,共纳入29例。
  • 终点为总生存和无进展生存。

主要发现

  • 5年总生存率为67.5%,5年无进展生存率为59.1%。
  • 吸烟史超过10包年与更差的总生存(P=0.02)和无进展生存(P=0.02)相关。
  • 缺乏人乳头瘤病毒DNA与更差的总生存(P=0.03)和无进展生存(P=0.02)相关。
  • 诱导化疗或根治性颈清扫未与不同的治疗结局相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We investigated the survival of patients with a p16-positive N3 oropharyngeal squamous cell carcinoma (OPSCC) and the prognostic significance of patient, tumor, and treatment characteristics. METHODS: We retrospectively reviewed the data of patients treated at our Cancer Center for a p16-positive N3 OPSCC between 2003 and 2016. End points were overall survival (OS) and progression-free survival (PFS). RESULTS: A total of 29 patients were included. The 5-year OS and PFS were 67.5% and 59.1%, respectively. Smoking history above 10 pack-years and the absence of human papillomavirus DNA were associated with worse OS (P = .02 and P = .03, respectively) and PFS (P = .02 and P = .02, respectively). Induction chemotherapy or radical neck dissection were not associated with different treatment outcomes. CONCLUSION: Patients with an N3 p16-positive oropharyngeal cancer in our series had a 5-year OS rate of 67.5%. Smoking history and viral DNA were prognostic factors associated with survival.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Gorphe P, Chekkoury Idrissi Y, Tao Y, et al. Smoking and papillomavirus DNA in patients with p16-positive N3 oropharyngeal squamous cell carcinoma. Head Neck. 2018. PMID: 30552841. doi:10.1002/hed.25523

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。